JAAD Online
A response to “Male balding is a major risk factor for severe COVID-19”

https://doi.org/10.1016/j.jaad.2020.10.051Get rights and content

Cited by (0)

Funding sources: None.

Conflicts of interest: Dr Wu is or has been an investigator, consultant, or speaker for AbbVie, Almirall, Amgen, Arcutis, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Dermavant, Dermira, Dr. Reddy's Laboratories, Eli Lilly, Janssen, LEO Pharma, Novartis, Regeneron, Sanofi Genzyme, Sun Pharmaceutical, UCB, and Valeant Pharmaceuticals North America LLC. The rest of the authors have no conflicts to disclose.

IRB approval status: Not applicable.

Reprints not available from the authors.

View Abstract